Flotrenizine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A4JO90697G. European Medicines Agency schedules Flotrenizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07656MIG. Flotrenizine generally arises in the molecular formula C31H38F2N2O. The term FLOTRENIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) FLOTRENIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flotrenizine under HS 29335995 and SITC 51576. As of Q4 2014, FLOTRENIZINE remains the US FDA Preferred Term for this commodity. Flotrenizine bears US NLM identifiers UMLS ID C1880795 and NCI Concept Code C65699. SMILES: FC1CCC(C(N2CCN(CC2)CCCC(O)C2CCC(C(C)(C)C)CC2)C2CCC(F)CC2)CC1.